Últimas noticias sobre Jasper Therapeutics (NASDAQ:JSPR) Bolsa

Jasper Therapeutics

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics Inc

Chinese battery manufacturer CATL (Contemporary Amperex Technology Co. Limited) has launched the second-generation ‘Shenxing' fast-charging battery.
What Happened: The company announced the second-generation battery at an event in Shanghai, reported Reuters on Monday. Shenxing batteries would power over 67 new EVs this year, CATL's Chief Technology Officer, Gao Huan, said.
The new battery would enable a range of 520 km or approximately 323 miles on a 5-minute charge. The battery can also be charged from 0% to 80% in 15 minutes in cold weather.
The report also shares that, besides the new battery, CATL also unveiled a new brand called Naxtra for the company's Sodium-ion batteries. Sodium-ion batteries could help reduce the risk of a fire in EVs, some experts suggest.
Why It Matters: Last year, CATL, whose customers also include the likes of Volkswagen AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VLKAF#OTC">VLKAF</a>) and Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>), was seeking over <a href="https://www.benzinga.com/news/24/07/39745306/tesla-supplier-catl-seeks-1-5b-funding-to-expand-global-ev-battery-supply-chain">$1.5 billion in funding</a> to bolster its EV battery supply chain.&nbsp;
Elsewhere, fast-charging tech throughout the globe is experiencing rapid development. Recently, leading Chinese automaker BYD Co., Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDF#OTC">BYDDF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDD#OTC">BYDD</a>) <a href="https://www.benzinga.com/trading-ideas/movers/25/04/44630091/teslas-ev-crown-at-risk-as-byd-closes-in-with-breakthrough-charging-tech">unveiled its fast-charging technology</a>, which could provide approximately 250 miles of range through a 5-minute charge.
In contrast, Tesla Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44245123/teslas-charging-empire-faces-headwinds-as-ev-market-stumbles">superchargers provide 170 miles</a> of range on a 10-minute charge, significantly lower than BYD's tech.
Check out more of Benzinga's Future Of Mobility coverage by <a href="https://www.benzinga.com/topic/mobility">following this link</a>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/tech/25/04/44892799/teslas-india-play-deepens-as-elon-musks-ev-giant-explores-alternate-semiconductor-supply-chains-amid-us-china-trade-war">Tesla&#8217;s India Play Deepens As Elon Musk&#8217;s EV Giant Explores Alternate Semiconductor Supply Chains Amid US-China Trade War</a></li>
</ul>
Image Via Shutterstock

News

Markets

Tech

General

BYDD

BYDDF

TSLA

VLKAF

Tesla Battery Supplier CATL Unveils New Fast-Charging Battery With 323-Mile Range In Five Minutes

The U.S. is accelerating the permitting process for 10 critical mineral production projects under the FAST-41 program following President Donald Trump's <a target="_blank" href="https://www.benzinga.com/government/regulations/25/03/44471105/trumps-executive-order-fuels-investor-speculation-over-alaskan-resources" rel="noreferrer noopener">executive order</a> to reduce the country's reliance on foreign mineral imports.
The initiative seeks to remove bureaucratic hurdles, secure essential minerals, and strengthen domestic supply chains.
"This is the first use of the Permitting Council's transparency authority, and we look forward to showcasing the many benefits the Federal Permitting Dashboard can bring to critical infrastructure projects," <a target="_blank" href="https://www.whitehouse.gov/articles/2025/04/trump-administration-advances-first-wave-of-critical-mineral-production-projects/" rel="noreferrer noopener">said</a> Manisha Patel, Acting Executive Director at the Permitting Council. "It's a vital tool for interagency coordination and efficient decision-making," he added.
The newly designated projects include major proposals across the country such as Perpetua Resources' (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPTA#NASDAQ">PPTA</a>) Stibnite Gold and Antimony Project in Idaho, Rio Tinto's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>) Resolution Copper Project in Arizona, Hecla Mining's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>) copper and silver mine in Montana, and Albemarle's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) expansion of the Silver Peak lithium mine in Nevada. Also included are Standard Lithium's direct lithium extraction site in Arkansas, Warrior Met Coal's metallurgical coal mine in Alabama, and the McDermitt Lithium Project in Oregon. Others include the Caldwell Canyon Phosphate Mine in Idaho, Lisbon Valley Copper in Utah, and Michigan Potash.
These projects are now subject to the FAST-41 framework, which provides enhanced interagency coordination and a centralized online dashboard for monitoring permitting progress. While the program doesn't waive environmental laws, it significantly improves process transparency and helps enforce clearer timelines.
The U.S. depends heavily on foreign sources, particularly China, for critical minerals such as lithium, copper, and rare earth elements, crucial for electric vehicles, military equipment, and consumer electronics. Lengthy permitting processes, which can take anywhere from <a target="_blank" href="https://www.benzinga.com/news/24/07/39870803/us-mine-development-delays-among-worlds-longest-second-only-to-zambia" rel="noreferrer noopener">10 to 29 years</a>, have hindered domestic production, forcing reliance on geopolitical competitors. By comparison, countries like Canada and Australia approve mines in two to five years, giving them a significant advantage in attracting investment and securing supply chains.
Even in Canada, where permitting is relatively faster, both leading candidates for prime minister—Mark Carney and Pierre Poilievre—have campaigned on promises to <a target="_blank" href="https://www.benzinga.com/25/04/44732611/canadian-politicians-promise-faster-project-approvals-ahead-of-april-28-elections" rel="noreferrer noopener">reduce mining bureaucracy</a> further.
"For too long, duplicative processes and regulatory paralysis have delayed the development of the minerals America needs," <a target="_blank" href="https://www.doi.gov/pressreleases/trump-administration-adds-key-mining-projects-fast-41" rel="noreferrer noopener">said</a> Adam Suess, Acting Assistant Secretary for Land and Minerals Management. "By cutting red tape and increasing accountability, we're making it clear that under President Trump, the United States is serious about being a global leader in critical minerals."
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44891559/chinas-gold-stash-soars-to-2292-tonnesand-its-still-buying" target="_blank" rel="noreferrer noopener">China's Central Bank's Gold Stash Spikes To 2,292 Tonnes And Beijing Is Still Buying</a></li>
</ul>
Photo by Juan Roballo via Shutterstock

Government

Large Cap

Regulations

Commodities

Politics

Legal

PPTA

Trump Administration Fast-Tracks Ten Domestic Critical Mineral Projects

William Blair analyst Stephen Sheldon initiates coverage on Zillow Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>) with a Market Perform rating.

Initiation

Analyst Ratings

William Blair Initiates Coverage On Zillow Gr with Market Perform Rating

Nano Dimension Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNDM#NASDAQ">NNDM</a>) ("Nano Dimension" or the "Company"), a leader in Digital Manufacturing solutions, today provided an update on Desktop Metal.
Desktop Metal, a subsidiary of Nano Dimension, has commenced a process to explore all available strategic alternatives to address its liabilities and liquidity needs. Desktop Metal has appointed Robert Warshauer to its Board of Directors and engaged Piper Sandler &amp; Co. and FTI Consulting, Inc. as financial advisers.
No assurances can be given as to the outcome or timing of the strategic review process. Nano Dimension plans to share additional details during its upcoming 2024 financial results and 2025 outlook call, expected to be held in late April 2025.

NNDM

Nano Dimension Announces Strategic Review for Desktop Metal to Address Liabilities and Liquidity Needs

Biotech

ZLAB

China's National Medical Products Administration Accepts Zai Lab's New Drug Application For Repotrectinib For Patients With NTRK-Positive Solid Tumors

QXO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NYSE">QXO</a>) ("QXO" or the "Company") announced today that its wholly owned subsidiary, Queen MergerCo, Inc. ("Merger Sub"), intends to offer $2 billion in Senior Secured Notes due 2032 (the "Notes"), subject to market and other conditions. Merger Sub was formed in connection with QXO's previously announced acquisition of Beacon Roofing Supply, Inc. ("Beacon") under the Agreement and Plan of Merger dated March 20, 2025 (the "Merger Agreement").
Merger Sub intends to use the proceeds from the offering of the Notes, along with borrowings under new senior secured credit facilities, proceeds from QXO's previously announced equity offerings, and available balance sheet cash, to fund the transactions contemplated by the Merger Agreement and pay related fees and expenses.
Upon consummation of the acquisition, Merger Sub will merge with and into Beacon, with Beacon surviving as a wholly owned subsidiary of QXO. The Notes will be guaranteed on a senior secured basis by each of Beacon's wholly owned domestic restricted subsidiaries that guarantees Beacon's new senior secured term loan facility. The Notes and the related guarantees will be secured by first-priority liens on substantially all of Beacon's and the subsidiary guarantors' material owned assets other than ABL Priority Collateral (as defined below) and by second-priority liens on substantially all of Beacon's and the subsidiary guarantors' inventory and accounts receivable and related assets (the "ABL Priority Collateral"), in each case subject to certain exceptions and permitted liens.
The issuance and sale of the Notes and the related guarantees have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any other jurisdiction, and the Notes and the related guarantees are being offered and sold only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act and to certain non-U.S. persons in offshore transactions outside the United States in reliance on Regulation S under the Securities Act.

QXO's Subsidiary Queen MergerCo Intends To Offer $2B In Senior Secured Notes Due 2032

In early 2009, when the financial crisis was still wreaking havoc, former Vice Chairman of Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) and former Chairman of Daily Journal Corporation, Charlie Munger, made an unusual choice that differentiated him from most investors.
While panic spread across global markets and stocks were being sold unthinkingly, Munger silently funnelled 71% of the Daily Journal Corporation's cash into suffering financial institutions, particularly Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) and Wells Fargo &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>).
This turned out to be a masterstroke. By 2013, the value of those investments had increased three-fold, significantly boosting the company's worth.
Using Mental Models, Not Market Predictions: Munger didn't depend on forecasts or gut instinct, Chris Franco <a href="https://cmqinvesting.substack.com/p/how-charlie-munger-made-millions-after-2008-crash?r=4gn514&amp;utm_medium=ios&amp;triedRedirect=true">noted</a> in the CMQ Investing newsletter. Instead, he pursued a structured way of thinking that he called a &#8220;latticework of mental models.&#8221; 
Three main models grounded his investment choices: the Circle of Competence (only invest in businesses you understand in-depth), the Margin of Safety (buy at a price so low that even if things go sideways, there is still upside), and Opportunity Cost (allocate capital only when the potential return is better than any other option available).
These models created a strong, rational foundation for action when others were unsure of how to negotiate with uncertainty.
Understanding the Psychology of a Market Collapse: <a href="https://www.benzinga.com/markets/25/03/44450390/charlie-mungers-investment-wisdom-if-people-werent-so-often-wrong-we-wouldnt-be-so-rich">Munger's success </a>was rooted in his thorough understanding of human psychology. He consciously made sure not to fall into mental traps like Social Proof (following the crowd), Loss Aversion (being afraid of losses more than valuing gains), and Availability Bias (giving undue importance to recent traumatic events like the 2008 collapse).
He was not influenced by falling prices or sensational headlines. Instead, he gauged intrinsic value and based his thinking on facts, not fear.
See Also: <a href="https://www.benzinga.com/25/04/44855242/charlie-munger-once-highlighted-how-warren-buffetts-lifelong-learning-made-berkshire-hathaways-success-possible-and-the-crucial-lesson-you-can-take-from-it">Charlie Munger Once Said Warren Buffett Is A &#8216;Learning Machine&#8217; And That&#8217;s What Lies Beneath Berkshire Hathaway&#8217;s Success From One Decade To Another</a>
Why Munger's Strategy Still Matters Munger's strategy reminds us of age-old lessons: think for yourself, invest only when you understand the business, and leverage the fear-driven mispricing when it occurs. Munger's 2009 trade remains an extraordinary example of how <a href="https://www.benzinga.com/markets/equities/25/04/44681817/charlie-munger-once-said-the-market-wont-do-exactly-what-you-want-when-you-want-as-tariff-jitters-and-wild-swings-remind-investors-why-long-term-thinking-matters">long-term planning and emotional regulation </a>can generate incredible outcomes.
Berkshire's Cash Strategy Echoes Munger's Playbook Warren Buffett's record cash pile at Berkshire Hathaway is an example of Charlie Munger's 2009 approach in action—wait for fear to drive value. Armando Gonzalez, founder of AI-powered research platform Bigdata.com <a href="https://fortune.com/2025/03/15/warren-buffett-berkshire-hathaway-stock-market-correction-cash-pile-acquisitions/">told</a> Fortune that Buffett's moves demonstrate clear foresight: selling $134 billion in equities and <a href="https://www.benzinga.com/markets/equities/24/11/42153356/is-warren-buffett-preparing-for-a-market-downturn-with-berkshire-hathaways-325b-cash-pile-analyst-says-internet-bubble-and-2008-crash-may-have-lessons">building a $334.2 billion cash pile </a>in expectation of market turmoil.
Like Munger, Buffett is deploying patience as a strategic edge that will give him an advantage over others. Gonzalez observed that Buffett is not chasing rebounds or attempting to time the bottom—he's waiting for real bargains to appear, where the risk-reward balance tips conclusively in his favor.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44779752/charlie-munger-says-investors-who-cant-handle-market-volatility-deserve-the-mediocre-result">Charlie Munger Says Investors Who Can&#8217;t Handle Market Volatility &#8216;Deserve the Mediocre Result&#8217;</a></li>
</ul>
Photo Courtesy: Kent Sievers on Shutterstock.com

Success Stories

Charlie Munger's Bold Bank Bets In 2008: A Masterclass In Rational Investing And How Warren Buffett Is Now Channeling That Same Patience With A $334 Billion Cash Pile

Needham analyst John Todaro maintains Bitdeer Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) with a Buy and lowers the price target from $15 to $13.

Price Target

BTDR

Needham Maintains Buy on Bitdeer Technologies, Lowers Price Target to $13

Highlights 54.8% Total Stockholder Return Under Refreshed Board and Management Team
Zevra Continues Growth Trajectory into a Global Commercial Rare Disease Company with Consistent Execution, New Product Launches, and Significant Financial Flexibility to Execute Strategic Plan
Urges Stockholders to Defend Board Independence from Majority Influence by Individual 2.8% Stockholder, Mangless, Who Had Three Nominees Elected to the Board in 2023
Mangless Has Not Detailed any Strategies, Plans, or New Ideas to Improve Zevra's Business and Appears Solely Focused on Replacing Two Highly Qualified Directors
Board and Management Urge Stockholders to Vote "FOR" Zevra's Highly-Qualified and Experienced Director Nominees on the WHITE Proxy Card &nbsp;
CELEBRATION, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- &nbsp;Zevra Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVRA#NASDAQ">ZVRA</a>) ("Zevra", or "the Company"), a commercial-stage company focused on providing therapies for people living with rare disease, today announced it has filed its definitive proxy statement with the&nbsp;U.S. Securities and Exchange Commission&nbsp;(the "SEC") in connection with the Company's 2025 Annual Meeting of Stockholders ("Annual Meeting"), which is scheduled to take place on&nbsp;May 29, 2025. Stockholders of record as of&nbsp;April 4, 2025 will be entitled to vote at the Annual Meeting.
Zevra's Board of Directors strongly recommends that stockholders vote "FOR" the Company's two highly-qualified directors up for re-election on the WHITE proxy card – Wendy L. Dixon, Ph.D and Tamara A. Favorito, both of whom bring extensive public company board experience and life sciences management expertise to the Zevra Board. Both of these independent directors have contributed valuable perspectives that have helped accelerate the Company's progress and execution of its strategic goals.
In conjunction with the definitive proxy filing, Zevra is mailing a letter to stockholders detailing the decisive action the Company has taken over the past two years to transform Zevra into a stronger, growth-oriented commercial organization, which is poised to continue to drive significant stockholder value. The letter also addresses the attempt by an individual stockholder, Daniel J. Mangless, to replace two highly qualified directors with his nominees who could disrupt the clear progress underway and jeopardize Zevra's ability to deliver long-term value for stockholders.

ZVRA

Zevra Therapeutics Board And Management Urge Stockholders to Vote "FOR" Zevra's Director Nominees on WHITE Proxy Card

Loop Capital analyst Laura Champine upgrades Norwegian Cruise Line (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) from Hold to Buy and announces $25 price target.

Upgrades

NCLH

Loop Capital Upgrades Norwegian Cruise Line to Buy, Announces $25 Price Target

Northwestern&nbsp;Mutual's 2025 Planning&nbsp;&amp;&nbsp;Progress Study <a href="https://news.northwesternmutual.com/2025-04-14-Americans-Believe-They-Will-Need-1-26-Million-to-Retire-Comfortably-According-to-Northwestern-Mutual-2025-Planning-Progress-Study">says</a> Americans now peg the comfortable retirement price tag at $1.26&nbsp;million. The figure stops scrolling thumbs, but it means wildly different things on Main Street. 
What To Know: For a teacher in Tulsa, it feels cosmic; for a Manhattan surgeon, it barely rents a pied‑à‑terre. Treat it for what it is: a conversation starter, not a universal invoice.
<h3 class="wp-block-heading">Run Your Own Math</h3>
Financial planners at Fidelity <a href="https://www.fidelity.com/viewpoints/retirement/how-much-do-i-need-to-retire">prefer a rule</a> that scales — save roughly 10 times your final salary. If Oliver retires on a $55,000 paycheck, $550,000 covers the gap his future Social Security check won't. Cynthia, earning $300,000, needs closer to $3 million. Your housing costs, health profile, and side‑hustle plans matter far more than someone else's median estimate.
See also: <a href="https://www.benzinga.com/personal-finance/25/04/44891462/how-to-put-100-in-your-retirement-fund-each-month-with-pfizer-stock">How To Put $100 In Your Retirement Fund Each Month With Pfizer Stock</a>
<h3 class="wp-block-heading">Build Flexibility Into the Blueprint</h3>
Retirement isn't a one‑button launch. Markets wobble, health changes, and parents need care. Draft a rolling budget today, adjust annually, and keep optional levers — like part‑time consulting or relocating to a lower‑tax ZIP code — <a href="https://www.benzinga.com/personal-finance/24/08/40316240/four-steps-to-secure-your-retirement-income">ready to pull</a>. Flexibility is a hedge no index fund can match.
<h3 class="wp-block-heading">Dreams, Discounted</h3>
Can't bankroll that ‘Mamma Mia!' fantasy villa? Pencil in month‑long Airbnb stints on a Greek isle instead. Big goals shrink gracefully when you swap permanence for experience. The point is crafting a life you control, not chasing a number someone else published.
Ignore headline heuristics; focus on personalized goals, disciplined saving, and on‑the‑fly adaptability. The right figure is the one that funds your version of enough, whether that's $500,000, $1.26 million, or something in between.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read next: <a href="https://www.benzinga.com/personal-finance/25/04/44889415/90-of-plans-offer-it-but-only-20-use-it-suze-orman-says-this-401k-feature-is-being-ignored-at-your-own-risk">90% of Plans Offer It, But Only 20% Use It — Suze Orman Says This 401(k) Feature Is Being Ignored at Your Own Risk</a>

Education

Study Says You Need $1.26 Million To Retire — Here's Why The Math Says Otherwise

Zevra Details Strong Growth, Director Re-Election and Strategic Vision for Rare Disease Treatments in Stockholder Letter Ahead of 2025 Annual Meeting

U.S. Vice President JD Vance has landed in New Delhi, India, for pivotal discussions with Prime Minister Narendra Modi, amid escalating global trade disputes.
What Happened: Vance arrived in Delhi on Monday, accompanied by his family. The Vice-President&#8217;s visit occurs amid rising trade tensions sparked by Donald Trump&#8216;s tariff policies. 
&#8220;The two sides will also exchange views on regional and global developments of mutual interest,&#8221; India&#8217;s foreign ministry stated ahead of Vance&#8217;s arrival, as per the <a href="https://www.bbc.com/news/articles/c793rzx3l7vo">BBC</a>. Formal talks with Prime Minister Modi are scheduled for later in the day, followed by a dinner hosted by Modi.
Vance and Modi are primarily expected to assess the progress made on the bilateral agenda set forth in February during Modi's meeting with President Trump in Washington. The agenda includes &#8220;fairness&#8221; in their two-way trade. However, as per Reuters, it is unlikely that the two sides will finalize any deals during the visit.
Secondly, India and the U.S. are set to finalize a defense partnership framework this year, with India also planning to procure and co-produce arms such as Javelin anti-tank missiles and Stryker infantry combat vehicles, according to a joint statement from their February meeting.
Vance&#8217;s tour of India is also considered notable, especially with Trump&#8217;s anticipated visit later this year for the Quad summit, where leaders from Australia and Japan will also be present. Both India and the U.S. are expected to finalize a defense partnership framework during the year.
Harsh Pant, foreign policy head at the Observer Research Foundation, told Reuters, &#8220;The fact that the U.S.-China tensions are ramping up, and Vance in particular seems to have taken a very high profile role in American diplomacy, also means that the visit assumes an added layer of significance.&#8221;
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/04/44885628/mark-cuban-says-health-insurance-shouldnt-exist-you-dont-have-to-grab-every-nickel-when-its-the-health-of-the-entire-country-at-stake" target="_blank" rel="noreferrer noopener">Mark Cuban Says Health Insurance Shouldn&#8217;t Exist — &#8216;You Don&#8217;t Have to Grab Every Nickel When It&#8217;s the Health of the Entire Country at Stake&#8217; &#8211; Benzinga</a>
Why It Matters: Trump, who has previously labeled India a tariff &#8220;abuser,&#8221; had announced a tariff of 26% on India before temporarily pausing it on April 9. New Delhi is hopeful of securing a trade deal with the U.S. within the 90-day pause on tariff hikes announced by Trump.
India has already lowered tariffs on certain U.S. goods since January, with additional cuts anticipated as the trade balance heavily favors Delhi, which currently holds a $45 billion trade surplus. These goods have included fish hydrolysate, synthetic flavoring essences, Ethernet switches, bourbon whiskey, and motorcycles. Moreover, the 6% Equalization Levy has been abolished, resolving concerns from the USTR regarding its effect on U.S. companies in India.
In 2024, the U.S. became India&#8217;s largest trading partner, with bilateral trade totaling $129 billion and India maintaining a $45.7 billion surplus, according to U.S. government trade data.
Prime Minister Modi was one of the first leaders to meet Trump after his inauguration, celebrating a &#8220;mega partnership&#8221; with the U.S. The two leaders set an ambitious goal to more than double bilateral trade<a href="https://www.benzinga.com/markets/25/02/43756977/trump-unveils-500-billion-trade-goal-to-supercharge-us-india-ties"> to $500 billion</a>, announcing a deal for India to increase imports from America, including oil and gas.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/25/04/44891213/joe-rogan-paints-a-picture-of-trump-in-between-golf-swings-hes-on-the-phone-with-other-presidents-were-going" target="_blank" rel="noreferrer noopener">Joe Rogan Paints A Picture Of Trump: In Between Golf Swings, He&#8217;s On The Phone With Other Presidents: &#8216;We&#8217;re Going To Need More Money!&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

JD Vance Arrives In New Delhi For Crucial Talks With India's Modi Amid Rising Trade Tensions

Management

IMVT

Immunovant Appoints Eric Venker (Currently President And COO Of Roivant) As CEO, Tiago Girao As CFO, Following Pete Salzmann's Retirement as CEO and Director

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAT#NASDAQ">PHAT</a>) with a Buy and maintains $28 price target.

Reiteration

PHAT

Needham Reiterates Buy on Phathom Pharmaceuticals, Maintains $28 Price Target

Barclays analyst Adrienne Yih initiates coverage on Abercrombie &amp; Fitch (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) with a Equal-Weight rating and announces Price Target of $71.

Barclays Initiates Coverage On Abercrombie & Fitch with Equal-Weight Rating, Announces Price Target of $71

Benchmark analyst David Williams maintains Belden (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDC#NYSE">BDC</a>) with a Buy and lowers the price target from $130 to $120.

Benchmark Maintains Buy on Belden, Lowers Price Target to $120

Net interest income is expected to be up slightly in 2Q25, relative to 1Q25, due to a stable NIM and an increased day count despite lower projected average and end of period loan balances. nDeposit balances are expected to be flat in 2Q25, relative to 1Q25. nWith current liquidity levels, we may increase debt security purchases during the remainder of 2025, if yields are attractive. nNoninterest income is expected to increase slightly during 2Q25, relative to 1Q25. nNoninterest expense expected to be between $31 million and $33 million per quarter in 2025. nAsset quality expected to remain solid, although a return to more normalized asset quality metrics and charge-offs may occur should the economy soften. Additionally, there may be more volatility in the CECL calculation if we see large movements in forecast unemployment and GDP. nStock repurchase program will continue to be used opportunistically with $15 million available through January 1, 2026. nCurrent capital levels and operational structure support M&amp;A should the right opportunity arise.

Guidance

HBT Projects Stable Net Interest Income and Modest Growth in Noninterest Income for 2Q25

JP Morgan analyst Richard Choe initiates coverage on Dycom Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DY#NYSE">DY</a>) with a Overweight rating and announces Price Target of $200.

JP Morgan Initiates Coverage On Dycom Industries with Overweight Rating, Announces Price Target of $200

As Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) trades within a narrow range, analysts urge traders to pivot away from momentum-driven strategies and adopt professional-grade trading techniques to profit in <a href="https://www.benzinga.com/money/bitcoin-price-prediction">a low-volatility environment</a>.
What Happened: A 10x Research report on Monday outlined how Bitcoin's sharp rallies in 2024 were limited to just two months, February (+44%) and November (+37%), while the rest of the year was characterized by consolidation.
Despite Bitcoin's strong annual return of +113%, the report emphasizes that most of the gains were compressed into brief windows, and that the current trading environment requires more tactical positioning.
"Bitcoin tends to perform better between October and March and consolidate between April and September," the analysts stated. "It makes sense to adopt a more conservative, seasonally aware approach during this part of the year."
The firm notes that retail participation has sharply declined in 2025, as evidenced by falling volumes during weekends and holidays, a shift that underscores the growing influence of institutional players.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44879425/bitcoin-to-outperform-gold-in-coming-months-says-anthony-pompliano">Bitcoin To Outperform Gold In Coming Months, Says Anthony Pompliano</a>
Why It Matters: Meanwhile, technical signals and on-chain metrics suggest caution.
The report identifies $73,000 as a likely downside limit but emphasizes the lack of strong upward catalysts in the near term.
Given this market backdrop, 10x Research suggests traders focus on structured strategies to generate yield or hedge risk. 
Among these, selling options in a range-bound market is seen as a particularly viable approach.
"With implied volatility dropping from 73% to 37% ahead of and following the April 6 decline, traders who sold puts were able to profit both from the fade in downside and from the volatility collapse," the report noted. 
This dual advantage, according to the analysts, reinforces the importance of monitoring volatility when constructing trades.
The research also highlights that when 1-month implied volatility falls below 40%, it is generally more favorable to buy options, either calls or puts. 
Conversely, when volatility exceeds 60%, selling options becomes more attractive.
"In the current environment, selling puts or calls around the 80% and 120% strike levels has proven relatively low-risk and potentially income-generating," the analysts wrote, noting that since January 2024, Bitcoin has only moved outside the ±20% range on two occasions out of sixteen.
10x Research contrasts the current cycle with previous ones, emphasizing that the key driver this time is not retail euphoria or halving supply shocks, but rather structured accumulation by existing holders and institutions. This includes long/short positions and arbitrage opportunities like shorting Ethereum perpetuals against Bitcoin or exploiting funding rate dislocations.
What&#8217;s Next: The decline in new Bitcoin addresses further supports the observation that new retail inflows are not driving the market.
"Capturing periodic upside moves now requires more active, tactical approaches rather than passively holding spot exposure," the report stated.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44869153/unrealized-bitcoin-losses-hit-all-time-high-glassnode-says-bear-market-signs">Unrealized Bitcoin Losses Hit All-Time High, Glassnode Says: Bear Market Signs?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

How Traders Can Make Money When Bitcoin Trades Sideways: 10x Research

Press Releases

Jasper Therapeutics to Participate at Upcoming Investor Conferences

Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a ETESIAN Clinical Study of Briquilimab in Asthma

Jasper Therapeutics to Host Webinar to Present Preliminary Data from the BEACON Study of Briquilimab in Chronic Spontaneous Urticaria on January 8, 2025

Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria

Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference

Health Care

Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Jasper Therapeutics to Present at Upcoming March Investor Conferences

Earnings

Jasper Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update

Jasper Therapeutics Announces Late-Breaking Briquilimab Presentation at the American Academy of Dermatology (AAD) Annual Meeting

Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Comments

Jasper Therapeutics

Noticias

Últimas noticias sobre Jasper Therapeutics (NASDAQ:JSPR) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL